Changes in the gut microbiome associated with infliximab in patients with bipolar disorder

OBJECTIVES: Available information exists supporting the gut–brain axis, but additional information is needed to explore how the gut microbiome changes when exposed to mood disorder treatments. We sought to explore the effects of a novel treatment for bipolar disorder (BD), infliximab, on the gut mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bharwani, Aadil, Szamosi, Jake C., Taylor, Valerie H., Lee, Yena, Bala, Asem, Mansur, Rodrigo, Subramaniapillai, Mehala, Surette, Michael, McIntyre, Roger S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413825/
https://www.ncbi.nlm.nih.gov/pubmed/34152099
http://dx.doi.org/10.1002/brb3.2259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413825/
https://www.ncbi.nlm.nih.gov/pubmed/34152099
http://dx.doi.org/10.1002/brb3.2259

Ejemplares similares